×
Back to Agenda
Industry in the Sunshine: How the “Sunshine” Provisions of the Affordable Care Act Will Change Industry Policy and Practice
Session Chair(s)
John Kamp
Washington Counsel, Coalition For Healthcare Communication (CHC), United States
Physician Payment Sunshine: A Ray of Hope or a Deeply Flawed Law?
Learning Objective : Discuss the First Amendment underpinnings of the IMS and Caronia court decisions including how those implicate the prescription marketing rules of the FDA; Recognize the importance of Citizen Petitions and other related actions by PhRMA, IWG and others; Identify the possible changes in FDA regulation likely in light of these rulings.
Speaker(s)
David Vulcano, MBA, RAC
CEO, ACRP | Association of Clinical Research Professionals, United States
Physician Payment Sunshine: A Ray of Hope or a Deeply Flawed Law?
Thomas Sullivan
President, Rockpointe Corporation, United States
Physician Payment Sunshine Act: Where Have We Gone and Where are We Going
Gary Shangold
Chief Executive Officer, Integurx Therapeutics LLC, United States
The Sunshine Act's Impact on the Research Profession and Its Impact on Manufacturers That Sponsor Clinical Trials
Have an account?